Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol sedation for recovery after colonoscopy in elderly patients
ChiCTR2200066689Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Dec 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam, propofol and sufentanil (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Cognitive recovery rate 3 days after colonoscopy. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
remimazolampropofolsufentanil
Beyond the preview
Go deeper on ChiCTR2200066689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066689.